Torrent Pharmaceuticals Share Price Live
Live Torrent Pharmaceuticals Share Price Chart
Torrent Pharmaceuticals Performance
Days Range
| Previous Close | ₹3,718.40 |
|---|---|
| Open | ₹3,721.4 |
| Volume | 86,004 |
| Day's Range | ₹3,705.10 - ₹3,752.70 |
|---|---|
| 52W Range | ₹2,886.45 - ₹3,882.20 |
| Market Cap | ₹1,25,835.13 Cr |
Torrent Pharmaceuticals F & O
Torrent Pharmaceuticals Fundamentals
| ROCE(TTM) | 27.37 |
|---|---|
| P/E Ratio (TTM) | 58.8 |
| P/B Ratio | 14.89 |
| Industry P/E | 32.86 |
| Debt to Equity | 0.33 |
| ROE | 25.33 |
| EPS (TTM) | 64.02 |
| Dividend Yield | 0.16 |
| Book Value | 249.66 |
| Face Value | 5 |
| ROCE(TTM) | 27.37 |
|---|---|
| P/E Ratio (TTM) | 58.8 |
| P/B Ratio | 14.89 |
| Industry P/E | 32.86 |
| Debt to Equity | 0.33 |
| ROE | 25.33 |
|---|---|
| EPS (TTM) | 64.02 |
| Dividend Yield | 0.16 |
| Book Value | 249.66 |
| Face Value | 5 |
Torrent Pharmaceuticals Financials
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|
| Net Sales | 2,762.00 | 2,909.00 | 3,128.00 | 3,246.00 |
| Expenses | 2,094.00 | 2,196.00 | 2,347.00 | 2,423.00 |
| Profit before tax | 691.00 | 665.00 | 738.00 | 791.00 |
| Operating Profit | 503.00 | 498.00 | 548.00 | 591.00 |
| Net Profit | 503.00 | 498.00 | 548.00 | 591.00 |
| ESP in Rs | 14.88 | 15.42 | 16.19 | 17.93 |
Torrent Pharmaceuticals Shareholding Pattern
| Held by | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoters | 71.25% | 68.31% | 68.31% | 68.31% | 68.31% |
| Flls | 14.46% | 16.17% | 16.31% | 16.09% | 15.92% |
| Dlls | 7.08% | 8.35% | 8.35% | 8.65% | 9.28% |
| Public | 7.21% | 7.17% | 7.03% | 6.95% | 6.49% |
About Torrent Pharmaceuticals
History of Torrent Pharmaceuticals Limited
Incorporated in 1972, Torrent Pharmaceuticals Limited is one of the leading pharma companies in India. It is a flagship company of the Torrent Group. The company is listed among the leaders in the therapeutic segment of Central Nervous System (CNS), Cardiovascular (CV), Vitamins Minerals Nutrients (VMN), Gastrointestinal (GI), Anti-diabetes (AD), Gynaecology, Dermatology and Pain. In 1980, the company set up their first manufacturing facility in Ahmedabad. In May 1994, the company released its IPO. Torrent Pharmaceuticals Ltd started expanding its business, and in 1998, it acquired Pharma-related investments and the business of Torrent Exports Limited. Since its inception, the company acquired several companies, including Heumann Pharma from Pfizer, Elder Pharmaceuticals Limited's India and Nepal Business, Zyg Pharma Private Limited, Unichem’s India and Nepal Business, Novartis Women Healthcare Brands and Curatio Health Care (I) Private Limited, which helped in strengthening the company’s position in the Indian Pharma market. The company has a presence in 40 countries in the world, including India, the USA, Brazil, Germany, etc. They have 7 manufacturing facilities in India and 1 Research and Development Facility in Gujarat. As of March 2023, the company had 644 approved patents for new API and formulation techniques for different geographies. They have more than 600 medical representatives and over 9,000 distributors.Business Segments of Torrent Pharmaceuticals Limited
The company has a presence in different segments as follows:- Therapeutic Segments: Under this segment, the company offers various pharmaceutical products for a wide range of areas, including Cardiovascular, Diabetology, Gastrointestinal, Pain Management and Anti-Infective. Some of the brands under this segment include Orlica 60, Nikoran, Lopamide, Ahaglow S Facewash, etc.
- Other Segments: The company also offers products for other treatments, such as Oncology, Nephrology, Pulmonology, Pediatric and Gynecology. The brands include Herwont Kit, Lymphtor, etc.
- Zao Torrent Pharma: This is a wholly-owned subsidiary of the company that is involved in the distribution of prescription drugs.
- Torrent Pharma Inc: This wholly-owned subsidiary of Torrent Pharmaceuticals Limited that takes care of the company’s operations in the USA.
- Heunet Pharma GmbH: This wholly-owned subsidiary of Torrent Pharmaceuticals Limited that markets and sells pharma products in Germany.
Key Personalities of Torrent Pharmaceuticals Limited
Samir Mehta, Chairman Samir Mehta is the Chairman of the Torrent Group. Under his guidance, Torrent Pharmaceuticals Limited was established as one of the leading and fast-growing pharma companies in India. He helped the company take several strategic initiatives and expand into new therapies and regions. Aman Mehta, Director Aman Mehta has been the Director of Torrent Pharmaceuticals Limited since August 2022. He has been part of several important integrations of the company and also market expansions and product launches. He is also the Director on the Board of Torrent Investments Private Limited, which is a holding company of the Torrent Group.Corporate Actions of Torrent Pharmaceuticals Limited
There are no records found on bonus shares, or stock splits from Torrent Pharmaceuticals Limited.Parent Organisation
Torrent
Managing Director
Samir Mehta
Founded
1972
NSE Symbol
TORNTPHARM
Top Mutual Funds Invested in Torrent Pharmaceuticals Share
Top Mutual Funds Invested in Torrent Pharmaceuticals Share
Peer Comparison
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,777.4 -3.40 (-0.19%) | ₹4,27,369.54 | 1,548.0 - 1,910.0 |
| Divis Laboratories Ltd | 6,405.5 46.50 (0.73%) | ₹1,68,802.18 | 4,955.0 - 7,071.5 |
| Cipla Ltd | 1,512.2 8.20 (0.55%) | ₹1,21,480.71 | 1,335.0 - 1,673.0 |
| Dr Reddys Laboratories Ltd | 1,236.1 9.90 (0.81%) | ₹1,02,220.23 | 1,020.0 - 1,405.9 |
| Zydus Lifesciences Ltd | 930.0 3.35 (0.36%) | ₹93,237.64 | 795.0 - 1,059.05 |
| Mankind Pharma Ltd | 2,240.9 18.20 (0.82%) | ₹91,632.38 | 2,115.1 - 3,054.8 |
Popular stocks
Torrent Pharmaceuticals Ltd FAQs
What is the share price of Torrent Pharmaceuticals Ltd (TORNTPHARM) shares?
Torrent Pharmaceuticals Ltd (TORNTPHARM) share price as of November 21, 2025, on NSE is Rs 3686.5 (NSE) and Rs 3686.5 (BSE) on BSE.
Can I buy Torrent Pharmaceuticals Ltd (TORNTPHARM) from Angel One?
Yes, You can buy Torrent Pharmaceuticals Ltd (TORNTPHARM) shares by opening a Demat account with Angel One.
How do I buy Torrent Pharmaceuticals Ltd (TORNTPHARM) from Angel One?
Torrent Pharmaceuticals Ltd (TORNTPHARM) share can be bought through the following modes:
1. Direct investment: You can buy Torrent Pharmaceuticals Ltd (TORNTPHARM) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Torrent Pharmaceuticals Ltd (TORNTPHARM) shares.
1. Direct investment: You can buy Torrent Pharmaceuticals Ltd (TORNTPHARM) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Torrent Pharmaceuticals Ltd (TORNTPHARM) shares.
What is the main business of Torrent Pharma?
The main business of Torrent Pharma is focused on conducting research and development along with manufacturing and marketing of generic formulations of pharmaceuticals. Its emphasis is on the therapeutic areas of the cardiovascular and central nervous systems.
Who are the promoters of Torrent Pharma?
The primary promoter of Torrent Pharma is Torrent Investments Private Limited.
What are the Subsidiaries that comes under Torrent Pharma?
Some of the subsidiaries that come under Torrent Pharma are Zao Torrent Pharma, Torrent Do Brasil Ltda., Torrent Pharma GmbH, Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH, Torrent Pharma Inc., Torrent Pharma Philippines Inc., and Laboratorios Torrent, S.A. de C.V.
